CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-26 | OYLER JOHN Chief Executive Officer | Sale | −805 | $141.98 | $114K | 24,255 |
| 2018-11-26 | Huang Jane CMO, Hematology | Exercise or conversion | +3,000 | $29.49 | $88K | 3,000 |
| 2018-11-26 | Huang Jane CMO, Hematology | Sale | −3,000 | $139.58 | $419K | 0 |
| 2018-11-26 | Huang Jane CMO, Hematology | Exercise or conversion · Share Option (Right to Buy) | +39,000 | 1,328,500 | ||
| 2018-11-19 | Glazer Donald W. Director | Gift | −3,138 | 4,133,802 | ||
| 2018-11-19 | Glazer Donald W. Director | Gift | −3,138 | 4,130,664 | ||
| 2018-11-19 | Glazer Donald W. Director | Gift | −3,138 | 4,127,526 | ||
| 2018-11-19 | Wang Xiaodong Director | Sale | −1,100 | $122.55 | $135K | 3,900 |
| 2018-11-19 | Wang Xiaodong Director | Sale | −1,277 | $123.68 | $158K | 2,623 |
| 2018-11-19 | Wang Xiaodong Director | Sale | −1,173 | $124.55 | $146K | 1,450 |
| 2018-11-19 | Wang Xiaodong Director | Sale | −850 | $125.56 | $107K | 600 |
| 2018-11-19 | Wang Xiaodong Director | Sale | −600 | $126.53 | $76K | 0 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Exercise or conversion | +12,067 | $29.10 | $351K | 12,067 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,958 | $111.10 | $329K | 9,109 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −4,000 | $112.18 | $449K | 5,109 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −2,527 | $113.03 | $286K | 2,582 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −1,173 | $113.92 | $134K | 1,409 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −700 | $114.96 | $80K | 709 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −500 | $116.56 | $58K | 209 |
| 2018-11-12 | Peterson Amy C. CMO, Immuno-oncology | Sale | −109 | $117.61 | $13K | 100 |
Page 108 of 123 · 2,455 trades